Related by context. Frequent words. (Click for all words.) 76 refractory chronic lymphocytic 75 liposomal formulation 74 Initiate Phase 74 multi kinase inhibitor 74 Presents Positive 73 Panzem R 73 Drug Candidate 73 HCV protease inhibitor 73 polymerase inhibitor 73 proteasome inhibitor 73 inhaled formulation 72 Daclizumab 72 forodesine 71 R sorafenib tablets 71 Inc. Nasdaq IMGN 71 Voreloxin 71 Clevudine 71 Initiates Phase 71 targeting CD# 71 humanized anti 71 Factor VIIa 70 AEG# 70 Pivotal Phase III 70 PEG SN# 70 anticancer compound 70 CYC# 70 orally bioavailable 70 developing Zerenex TM 70 Racivir 70 Clinical Trial Results 70 Tesetaxel 70 transcriptase inhibitor NNRTI 69 Denufosol 69 Nexavar ® 69 TLR9 agonist 69 Epratuzumab 69 Preclinical Data 69 HCV protease 69 Completes Enrollment 69 CRTX 69 Belimumab 69 FDA Accepts 69 Phase III Clinical Trial 69 elotuzumab 69 Idera Pharmaceuticals 69 Thiarabine 69 Cethromycin 69 KNS # 69 MKC# 69 ACHN 69 Phase Ib II 69 Phase 2b clinical trials 69 phase IIb clinical 69 NovaBay Pharmaceuticals 69 nucleoside reverse transcriptase inhibitor 69 Pivotal Study 69 INCB# [001] 69 SAR# [004] 69 fusion inhibitor 68 polymerase inhibitors 68 VQD 68 non nucleoside polymerase 68 Recombinant Human 68 Boceprevir 68 Mipomersen 68 JAK1 68 mTOR inhibitor 68 Inc Therapeutic Competitors 68 MEK inhibitor 68 Aliskiren 68 Dasatinib 68 DDP# 68 Patient Enrollment 68 novel orally administered 68 AVE# 68 Dapagliflozin 68 Irinotecan 68 II Clinical Trial 68 selectively inhibits 68 Copegus R 68 PSN# [002] 68 KRN# 68 Metastatic Melanoma 68 fumarate 68 Phase Ib clinical 68 IDIX 68 Single Dose 68 Guanilib 68 ongoing Phase 1b 67 ferric citrate 67 GRNVAC1 67 Onalta 67 Ambrisentan 67 GVAX R 67 NASDAQ LGND 67 DVAX 67 Traficet EN 67 IMMU 67 humanized monoclonal antibody 67 EZN 67 Pivotal Phase